Alveolar type II cells inhibit fibroblast proliferation: role of IL-1α
Open Access
- 1 February 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 290 (2) , L307-L316
- https://doi.org/10.1152/ajplung.00102.2005
Abstract
Alveolar type II (ATII) cells inhibit fibroblast proliferation in coculture by releasing or secreting a factor(s) that stimulates fibroblast production of prostaglandin E2(PGE2). In the present study, we sought to determine the factors released from ATII cells that stimulate PGE2production in fibroblasts. Exogenous addition of rat IL-1α to cultured lung fibroblasts induced PGE2secretion in a dose-response manner. When fibroblasts were cocultured with rat ATII cells, IL-1α protein was detectable in ATII cells and in the coculture medium between days 8 and 12 of culture, correlating with the highest levels of PGE2. Furthermore, under coculture conditions, IL-1α gene expression increased in ATII cells (but not fibroblasts) compared with either cell cultured alone. In both mixed species (human fibroblasts-rat ATII cells) and same species cocultures (rat fibroblasts and ATII cells), PGE2secretion was inhibited by the presence of IL-1 receptor antagonist (IL-1Ra) or selective neutralizing antibody directed against rat IL-1α (but not IL-1β). Conditioned media from cocultures inhibited fibroblast proliferation, and this effect was abrogated by the addition of IL-1Ra. Addition of keratinocyte growth factor (KGF) resulted in an earlier increase in PGE2secretion and fibroblast inhibition ( day 8 of coculture). This effect was inhibited by indomethacin but was not altered by IL-1Ra. We conclude that in this coculture system, IL-1α secretion by ATII cells is one factor that stimulates PGE2production by lung fibroblasts, thereby inhibiting fibroblast proliferation. In addition, these studies demonstrate that KGF enhances ATII cell PGE2production through an IL-1α-independent pathway.Keywords
This publication has 42 references indexed in Scilit:
- Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammationCurrent Opinion in Pharmacology, 2004
- The role of interleukin-1 in the pathogenesis of rheumatoid arthritisRheumatology, 2004
- Decreased prostaglandin E2 synthesis by lung fibroblasts isolated from rats with bleomycin‐induced lung fibrosisInternational Journal of Experimental Pathology, 1999
- Early and Persistent Alterations in the Expression of Interleukin-1α, Interleukin-1β and Tumor Necrosis Factor α mRNA Levels in Fibrosis-Resistant and Sensitive Mice after Thoracic IrradiationRadiation Research, 1996
- Co‐expression of TNFα and IL‐1β in human acute pulmonary fibrotic diseases: An immunohistochemical analysisPathology International, 1996
- Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.Journal of Clinical Investigation, 1995
- Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.Journal of Clinical Investigation, 1993
- Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair.Environmental Health Perspectives, 1993
- Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.Journal of Clinical Investigation, 1986
- Metabolic properties and ultrastructure of alveolar type II cells isolated with elastaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980